DNA synthesis technologies, supported by automated synthesizers, high-throughput platforms, oligonucleotide production ...

The global DNA synthesis market is projected to grow from $5.7 billion in 2025 to $30.4 billion by 2035, according to a new ...

As biotechnology becomes more routine, biosafety practices should account for what can persist after disposal—not only ...

The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...

The global DNA Polymerase Market is projected to expand from USD 397.7 million in 2025 to USD 725.8 million by 2035, growing at a CAGR of 6.2% during the forecast period. According to Future Market ...

A routine experiment with a new single-cell DNA sequencing method turned into a surprising scientific twist when researchers ...

Data just published on bioRxiv shows Sidewinder achieves first-of-its-kind realization of scalable parallel DNA construction, demonstrating ...

Ming, Professor of the Department of Chemical and Biological Engineering (CBE) at The Hong Kong University of Science and ...

Platform data establish Modified DNA’s potential to overcome two of the barriers that have kept DNA from becoming a practical ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

Engineered microorganisms are widely used in industrial biotechnology and biopharmaceutical applications, including the production of biofuels, sustainable chemicals, and therapeutic compounds.

SG293 represents a differentiated in vivo CAR T cell approach designed to work without lymphodepletion to deliver potent therapeutic activity and exceptional specificity to minimize off-target effects ...